Equity
€537,623 ▼ 22.0%
BODRI paid out €380,841 in dividends. That is 166% of the 2025 profit.
BODRI
Lifetime
13 annual accounts with figures on one time axispeak €491,630 (2024)
€484,721▼ 1.4%
peak €330,518 (2024)
€229,132▼ 30.7%
peak €689,332 (2024)
€537,623▼ 22.0%
€877,317▲ 202%
Board1 name since 2012
1 director
Documentsfilings and deeds
25-06-202636 days before the deadline
2025micro format
Result from €330,518 to €229,132Dividend €380,841Equity from €689,332 to €537,623Debts from €290,541 to €877,317Investments €843,129Cash from €472,023 to €307,013
Key points
from the 2025 annual accountsResult
€229,132 ▼ 30.7%
The result fell in 2025 from €330,518 to €229,132.
Debts
€877,317 ▲ 202%
Debts rose by €586,775 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.
Investments
€843,129 6.5 × depreciation
Green is investment, beige is depreciation. Land and buildings stand 12530.9% higher than in 2024.
Filings
13 annual accounts since 2013
The last five annual accounts were filed 3 to 118 days before the end of the period.
Position in the sector
€229,132
Higher net result than 91% of companies in human health. Sector median €59,563 · 21,317 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 17,811 companies had the same profile as BODRI has now. Each dot stands for 45 companies, two years later.
96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 17,811 companies, not a prediction for BODRI. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Purpose change
“uitbreiding met organiseren van congressen, opleidingen, teambuildings en andere evenementen” (deed in Dutch) · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0848838288
Company renamed from DR. to BODRI
Change of role: , from manager to director · Gazette deed
Incorporation
published on 01-10-2012 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| BODRI Duffel | €1.4m | €484,721 | 38.0% | - |
| DR BARTHOLOMEEUSEN ELLEN Brasschaat | €1.5m | €447,242 | 92.9% | - |
| DOKTER JORIS BECK Antwerp | €1.5m | €528,507 | 90.4% | - |
| FREDERIK VAN SONHOVEN Westerlo | €1.3m | €510,019 | 75.8% | - |
| DR. INGRID VAN DER DONCK Boom | €1.4m | €546,978 | 91.4% | - |
| DR. VAN DEN STEEN G. EN DR. GORISSEN J. Aartselaar | €1.4m | €471,028 | 67.8% | - |
| DR. A. LAUWERS-ANESTHESIST Bonheiden | €1.5m | €557,349 | 87.1% | - |
These companies have the same main activity as BODRI: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.3m and €1.5m, founded between 2010 and 2013.
Official details
Source: KBO- Status
- Active since 13-09-2012Normal situation
- Activity
- Specialist medical practiceNACE 86220and 3 others
- Establishment unit
- 2.213.038.8652570 Duffel, since 13-09-2012
- Financial year end
- 31 December
- Peppol
- Reachable since 15-12-2025
Annual accounts 2025
- ≈ €730,000estimated
- €1.4m▲ 44.4%
- ≈ 0.1 FTEestimated
- Filing
- Filed on 25-06-2026, 36 days before the end of the filing period
Insights on BODRI
BODRI files the micro format. That format states no turnover. The gross margin rose from €57,451 in 2013 to €484,721 in 2025.
The balance sheet grew most from 2023 to 2025 through fixed assets.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about BODRI
- What is the company number of BODRI?
- The company number of BODRI is 0848.838.288. The VAT number is the same number with BE in front: BE 0848.838.288.
- Where is BODRI based?
- The registered office is at Lintseheide 5, 2570 Duffel.Company details
- What does BODRI do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of BODRI?
- BODRI is a private limited company (BV).
- When was BODRI founded?
- BODRI was founded on 13-09-2012.
- Is BODRI still active?
- Yes, BODRI is an active enterprise in the KBO register.
- What is the turnover of BODRI?
- The turnover in financial year 2025 is ≈ €730,000. This figure is estimated from the gross margin of €484,721 and 31 comparable companies (NACE 86220). It probably lies between €650,000 and €1.0m.Financials
- Is BODRI profitable?
- In financial year 2025, BODRI made a profit of €229,132.
- Where can I find the annual accounts of BODRI?
- BODRI filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of BODRI due?
- BODRI must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.